Literature DB >> 30319057

Human-Monkey Chimeras for Modeling Human Disease: Opportunities and Challenges.

Alejandro De Los Angeles1, Insoo Hyun2, Stephen R Latham3, John D Elsworth1, D Eugene Redmond4.   

Abstract

The search for a better animal model to simulate human disease has been a "holy grail" of biomedical research for decades. Recent identification of different types of pluripotent stem (PS) cells and advances in chimera research might soon permit the generation of interspecies chimeras from closely related species, such as those between humans and other primates. In this study, we suggest that the creation of human-primate chimeras-specifically, the transfer of human stem cells into (non-ape) primate hosts-could not only surpass the limitations of current monkey models of neurological and psychiatric disease but would also raise important ethical considerations concerning the use of monkeys in invasive research. Questions regarding the scientific value and ethical concerns raised by the prospect of human-monkey chimeras are more urgent in light of recent advances in PS cell research and attempts to generate interspecies chimeras between humans and animals. While some jurisdictions prohibit the introduction of human PS cells into monkey preimplantation embryos, other jurisdictions may permit and even encourage such experiments. Therefore, it is useful to consider blastocyst complementation experiments more closely in light of advances that could make these chimeras possible and to consider the ethical and political issues that are raised.

Entities:  

Keywords:  disease modeling; interspecies chimera; naive pluripotent stem cells; neurological disease; pluripotent stem cells; psychiatric disease

Mesh:

Year:  2018        PMID: 30319057      PMCID: PMC7366261          DOI: 10.1089/scd.2018.0162

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  39 in total

1.  Is pharma running out of brainy ideas?

Authors:  Greg Miller
Journal:  Science       Date:  2010-07-30       Impact factor: 47.728

2.  Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine.

Authors:  J D Jentsch; D E Redmond; J D Elsworth; J R Taylor; K D Youngren; R H Roth
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

Review 3.  Naive and primed pluripotent states.

Authors:  Jennifer Nichols; Austin Smith
Journal:  Cell Stem Cell       Date:  2009-06-05       Impact factor: 24.633

4.  Human iPSC Glial Mouse Chimeras Reveal Glial Contributions to Schizophrenia.

Authors:  Martha S Windrem; Mikhail Osipovitch; Zhengshan Liu; Janna Bates; Devin Chandler-Militello; Lisa Zou; Jared Munir; Steven Schanz; Katherine McCoy; Robert H Miller; Su Wang; Maiken Nedergaard; Robert L Findling; Paul J Tesar; Steven A Goldman
Journal:  Cell Stem Cell       Date:  2017-07-20       Impact factor: 24.633

Review 5.  The Exceptional Vulnerability of Humans to Alzheimer's Disease.

Authors:  Lary C Walker; Mathias Jucker
Journal:  Trends Mol Med       Date:  2017-05-05       Impact factor: 11.951

6.  Interspecies Chimerism with Mammalian Pluripotent Stem Cells.

Authors:  Jun Wu; Aida Platero-Luengo; Masahiro Sakurai; Atsushi Sugawara; Maria Antonia Gil; Takayoshi Yamauchi; Keiichiro Suzuki; Yanina Soledad Bogliotti; Cristina Cuello; Mariana Morales Valencia; Daiji Okumura; Jingping Luo; Marcela Vilariño; Inmaculada Parrilla; Delia Alba Soto; Cristina A Martinez; Tomoaki Hishida; Sonia Sánchez-Bautista; M Llanos Martinez-Martinez; Huili Wang; Alicia Nohalez; Emi Aizawa; Paloma Martinez-Redondo; Alejandro Ocampo; Pradeep Reddy; Jordi Roca; Elizabeth A Maga; Concepcion Rodriguez Esteban; W Travis Berggren; Estrella Nuñez Delicado; Jeronimo Lajara; Isabel Guillen; Pedro Guillen; Josep M Campistol; Emilio A Martinez; Pablo Juan Ross; Juan Carlos Izpisua Belmonte
Journal:  Cell       Date:  2017-01-26       Impact factor: 41.582

7.  The ethics of experimenting with human brain tissue.

Authors:  Nita A Farahany; Henry T Greely; Steven Hyman; Christof Koch; Christine Grady; Sergiu P Pașca; Nenad Sestan; Paola Arlotta; James L Bernat; Jonathan Ting; Jeantine E Lunshof; Eswar P R Iyer; Insoo Hyun; Beatrice H Capestany; George M Church; Hao Huang; Hongjun Song
Journal:  Nature       Date:  2018-04       Impact factor: 49.962

8.  Neural blastocyst complementation enables mouse forebrain organogenesis.

Authors:  Amelia N Chang; Zhuoyi Liang; Hai-Qiang Dai; Aimee M Chapdelaine-Williams; Nick Andrews; Roderick T Bronson; Bjoern Schwer; Frederick W Alt
Journal:  Nature       Date:  2018-10-10       Impact factor: 49.962

9.  Human glia can both induce and rescue aspects of disease phenotype in Huntington disease.

Authors:  Abdellatif Benraiss; Su Wang; Stephanie Herrlinger; Xiaojie Li; Devin Chandler-Militello; Joseph Mauceri; Hayley B Burm; Michael Toner; Mikhail Osipovitch; Qiwu Jim Xu; Fengfei Ding; Fushun Wang; Ning Kang; Jian Kang; Paul C Curtin; Daniela Brunner; Martha S Windrem; Ignacio Munoz-Sanjuan; Maiken Nedergaard; Steven A Goldman
Journal:  Nat Commun       Date:  2016-06-07       Impact factor: 14.919

Review 10.  The daunting polygenicity of mental illness: making a new map.

Authors:  Steven E Hyman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-03-19       Impact factor: 6.237

View more
  1 in total

Review 1.  Length of the Neurogenic Period-A Key Determinant for the Generation of Upper-Layer Neurons During Neocortex Development and Evolution.

Authors:  Barbara K Stepien; Samir Vaid; Wieland B Huttner
Journal:  Front Cell Dev Biol       Date:  2021-05-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.